Efficacy and selectivity of phosphodiesterase-targeted drugs in inhibiting photoreceptor phosphodiesterase (PDE6) in retinal photoreceptors.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Investigative Ophthalmology and Visual Science

• Publication date

  2005-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1167/IOVS.05-0257PMID 16123402PMCID PMC1343468
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Purification of PDE6 isozymes from mammalian retina.

  2005cited by this paper
• cGMP signaling in vertebrate retinal photoreceptor cells.

  2005cited by this paper
• Cyclic GMP and Phosphodiesterase 5 Inhibitor Therapies: What's on the Horizon?

  2004cited by this paper
• Differential inhibitor sensitivity between human recombinant and native photoreceptor cGMP-phosphodiesterases (PDE6s).

  2004cited by this paper
• Binding of tritiated sildenafil, tadalafil, or vardenafil to the phosphodiesterase-5 catalytic site displays potency, specificity, heterogeneity, and cGMP stimulation.

  2004cited by this paper
• Handbook of cell signaling

  2004cited by this paper
• Crystal Structures of Phosphodiesterases 4 and 5 in Complex with Inhibitor 3-Isobutyl-1-methylxanthine Suggest a Conformation Determinant of Inhibitor Selectivity*

  2004cited by this paper
• Retinal diseases linked with photoreceptor guanylate cyclase

  2004cited by this paper
• Characteristics of Photoreceptor PDE (PDE6): similarities and differences to PDE5

  2004cited by this paper
• Current and future trends in the oral pharmacotherapy of male erectile dysfunction

  2003cited by this paper
• Structure of the catalytic domain of human phosphodiesterase 5 with bound drug molecules

  2003cited by this paper
• Phosphodiesterases as therapeutic targets.

  2003cited by this paper
• CHAPTER 196 – Structure, Function, and Regulation of Photoreceptor Phosphodiesterase (PDE6)

  2003cited by this paper
• Cyclic nucleotide phosphodiesterase 5 and sildenafil: promises realized.

  2003cited by this paper
• [3H]sildenafil binding to phosphodiesterase-5 is specific, kinetically heterogeneous, and stimulated by cGMP.

  2003cited by this paper
• Regulation of Photoreceptor Phosphodiesterase (PDE6) by Phosphorylation of Its Inhibitory γ Subunit Re-evaluated*

  2002cited by this paper
• G proteins and phototransduction.

  2002cited by this paper
• Viagra (sildenafil citrate) and ophthalmology.

  2002influential reference
• The Catalytic and GAF Domains of the Rod cGMP Phosphodiesterase (PDE6) Heterodimer Are Regulated by Distinct Regions of Its Inhibitory γ Subunit*

  2001cited by this paper
• Cyclic nucleotide phosphodiesterases: relating structure and function.

  2001cited by this paper
• Molecular mechanisms in visual transduction

  2000cited by this paper
• Identification of the gamma subunit-interacting residues on photoreceptor cGMP phosphodiesterase, PDE6alpha '.

  2000cited by this paper
• Kinetics and regulation of cGMP binding to noncatalytic binding sites on photoreceptor phosphodiesterase.

  2000cited by this paper
• Chapter 5 Phototransduction in vertebrate rods and cones: Molecular mechanisms of amplification, recovery and light adaptation

  2000cited by this paper
• Identification of the γ Subunit-interacting Residues on Photoreceptor cGMP Phosphodiesterase, PDE6α′*

  2000cited by this paper
• Potency and mechanism of action of E4021, a type 5 phosphodiesterase isozyme-selective inhibitor, on the photoreceptor phosphodiesterase depend on the state of activation of the enzyme.

  1999cited by this paper
• Regulation of photoreceptor phosphodiesterase catalysis by its non-catalytic cGMP-binding sites.

  1999cited by this paper
• Calcium Overload Triggers Rod Photoreceptor Apoptotic Cell Death in Chemical‐Induced and Inherited Retinal Degenerations

  1999cited by this paper
• Photoreceptor Guanylate Cyclases: A Review

  1997cited by this paper
• Mechanism of photoreceptor cGMP phosphodiesterase inhibition by its gamma-subunits.

  1996cited by this paper
• From mice to men: the cyclic GMP phosphodiesterase gene in vision and disease. The Proctor Lecture.

  1995cited by this paper
• cGMP binding sites on photoreceptor phosphodiesterase: role in feedback regulation of visual transduction.

  1994cited by this paper
• Rod outer segment structure influences the apparent kinetic parameters of cyclic GMP phosphodiesterase

  1994cited by this paper
• Amplification and kinetics of the activation steps in phototransduction.

  1993cited by this paper
• Intracellular cGMP concentration in rod photoreceptors is regulated by binding to high and moderate affinity cGMP binding sites.

  1993cited by this paper
• Comparative Effects of Phosphodiesterase Inhibitors on Detached Rod Outer Segment Function

  1990cited by this paper
• [Phosphodiesterase inhibitors].

  1990cited by this paper
• Inhibition and stimulation of photoreceptor phosphodiesterases by dipyridamole and M&B 22,948.

  1989cited by this paper
• Metabolic flux of cyclic GMP and phototransduction in rabbit retina.

  1988cited by this paper
• Control of light‐sensitive current in salamander rods.

  1988cited by this paper
• The effects of phosphodiesterase inhibitors and lanthanum ions on the light‐sensitive current of toad retinal rods.

  1986cited by this paper
• Rapid declines in cyclic GMP of rod outer segments of intact frog photoreceptors after illumination.

  1986cited by this paper
• Reciprocal control of retinal rod cyclic GMP phosphodiesterase by its gamma subunit and transducin.

  1986cited by this paper
• Reciprocal control of retinal rod cyclic GMP phosphodiesterase by its γ subunit and transducin

  1986cited by this paper
• Light-induced decreases in cGMP concentration precede changes in membrane permeability in frog rod photoreceptors.

  1984cited by this paper
• Antagonism between steady light and phosphodiesterase inhibitors on the kinetics of rod photoresponses.

  1982cited by this paper
• Influence of calcium on guanosine 3',5'-cyclic monophosphate levels in frog rod outer segments

  1981cited by this paper
• Cyclic GMP accumulation causes degeneration of photoreceptor cells: simulation of an inherited disease.

  1977cited by this paper
• Electrical and adaptive properties of rod photoreceptors in bufo marinus. II. Effects of cyclic nucleotides and protaglandins

  1977cited by this paper
• Topology of the Outer Segment Membranes of Retinal Rods and Cones Revealed by a Fluorescent Probe

  1974cited by this paper
• Cyclic Guanosine Monophosphate: Elevation in Degenerating Photoreceptor Cells of the C3H Mouse Retina

  1974cited by this paper
• Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

  1973cited by this paper
• Characterization and Analysis of Frog Photoreceptor Membranes

  1971cited by this paper

• Naringenin and quercetin alter mouse rod phototransduction kinetics in a manner consistent with phosphodiesterase-6 inhibition.

  2026cites this paper
• Estrogen receptor 1 activation suppresses microglia-derived Tnf-α signaling as a photoreceptor self-protection mechanism

  2025cites this paper
• Roles of Cyclic Nucleotide Phosphodiesterases in Signal Transduction Pathways in the Nematode Caenorhabditis elegans

  2025cites this paper
• Impact of Second-Generation PDE 5 Inhibitor, Avanafil, on Retinal Function: Studies From Ex Vivo ERG

  2025cites this paper
• Photopic flicker optoretinography captures the light-driven length modulation of photoreceptors during phototransduction

  2025cites this paper
• Inhibiting HMGB1/AGER/NF-κB pathway prevents pro-inflammatory microglia polarization and protect photoreceptors in retinitis pigmentosa.

  2025cites this paper
• Defining proteoform-specific interactions for drug targeting in a native cell signalling environment

  2025cites this paper
• Cyclic nucleotide phosphodiesterases as drug targets.

  2025cites this paper
• Free fatty acid receptor 4 in cardiac myocytes ameliorates ischemic cardiomyopathy

  2024cites this paper
• Mechanism investigation of highly selective inhibitors toward phosphodiesterase 5 and 6 via the in vitro calculation and simulation

  2024cites this paper
• New Improved cGMP Analogues to Target Rod Photoreceptor Degeneration

  2024cites this paper
• Possible Retinotoxicity of Long-term Vardenafil Treatment.

  2024cites this paper
• Tadalafil Rescues the p.M325T Mutant of Best1 Chloride Channel

  2023influential citation
• Central retinal vein and artery occlusion associated with sildenafil: a case report and review of the literature

  2023cites this paper
• Inhibition of altered Orai1 channels in Müller cells protects photoreceptors in retinal degeneration

  2023cites this paper
• Photoreceptor Phosphodiesterase (PDE6): Activation and Photoreceptor Phosphodiesterase (PDE6): Activation and Inactivation Mechanisms During Visual Transduction in Rods and Inactivation Mechanisms During Visual Transduction in Rods and Cones Cones

  2023cites this paper
• Effects of Phosphodiesterase-5 Inhibitors in Patients with Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis

  2022cites this paper
• The regulatory landscape of retinoblastoma: a pathway analysis perspective

  2022cites this paper
• VCP/p97 inhibitor CB-5083 modulates muscle pathology in a mouse model of VCP inclusion body myopathy

  2022cites this paper
• G-Protein Coupled Receptor Signaling and Mammalian Target of Rapamycin Complex 1 Regulation

  2021cites this paper
• GPCR Signaling and mTORC1 Regulation

  2021cites this paper
• Cyclic nucleotide phosphodiesterase inhibition as a potential therapeutic target in renal ischemia reperfusion injury.

  2021cites this paper
• Sildenafil in Ophthalmology: An update.

  2021cites this paper
• New In Vitro Cellular Model for Molecular Studies of Retinitis Pigmentosa

  2021cites this paper
• Photoreceptor Phosphodiesterase (PDE6): Structure, Regulatory Mechanisms, and Implications for Treatment of Retinal Diseases.

  2021influential citation
• A p97/Valosin-Containing Protein Inhibitor Drug CB-5083 Has a Potent but Reversible Off-Target Effect on Phosphodiesterase-6

  2021influential citation
• Functional modulation of phosphodiesterase-6 by calcium in mouse rod photoreceptors

  2021cites this paper
• Photoreceptor phosphodiesterase (PDE6): activation and inactivation mechanisms during visual transduction in rods and cones

  2021cites this paper
• Sildenafil-evoked photoreceptor oxidative stress in vivo is unrelated to impaired visual performance in mice

  2021cites this paper
• PDE1 or PDE5 inhibition augments NO‐dependent hypoxic constriction of porcine coronary artery via elevating inosine 3′,5′‐cyclic monophosphate level

  2020cites this paper
• Progressive effects of sildenafil on visual processing in rats.

  2020cites this paper
• Cellular mechanisms of hereditary photoreceptor degeneration - Focus on cGMP.

  2020cites this paper
• PEDF peptides promote photoreceptor survival in rd10 retina models.

  2019cites this paper
• Association of Transient Colorblindness With Sildenafil and Tadalafil.

  2019cites this paper
• Availability of multistep light stimulus method for evaluation of visual dysfunctions.

  2019cites this paper
• Cryo-EM structure of phosphodiesterase 6 reveals insights into the allosteric regulation of type I phosphodiesterases

  2019cites this paper
• Phosphodiesterases as therapeutic targets for respiratory diseases.

  2019cites this paper
• Role of the nitric oxide-soluble guanylyl cyclase pathway in cognitive deficits in streptozotocin-induced diabetic rats

  2019cites this paper
• An update on the drug safety of treating erectile dysfunction

  2019cites this paper
• Exploration of icariin analog structure space reveals key features driving potent inhibition of human phosphodiesterase-5

  2019cites this paper
• Kiwifruit extract attenuates tadalafil induced retinal injury in adult male albino rats: a histological and immunohistochemical study

  2019cites this paper
• PDE5 inhibition improves symptom-free survival and restores transverse tubule loss and catecholamine responsiveness in heart failure

  2019cites this paper
• Phosphodiesterase 5 inhibition improves contractile function and restores transverse tubule loss and catecholamine responsiveness in heart failure

  2018cites this paper
• PKG-Dependent Cell Death in 661W Cone Photoreceptor-like Cell Cultures (Experimental Study).

  2018cites this paper
• An immunohistochemical and ultrastructural analysis of the retina in tadalafil (Cialis) treated rats.

  2018cites this paper
• Xanthine scaffold: scope and potential in drug development

  2018cites this paper
• Electrophysiological determination of phosphodiesterase‐6 inhibitor inhibition constants in intact mouse retina

  2018influential citation
• Visual impairment with possible macular changes after a high dose of sildenafil in a healthy young woman.

  2018cites this paper
• Retinal Cell Biology Phosphodiesterase Inhibitors Sildenafil and Vardenafil Reduce Zebrafish Rod Photoreceptor Outer Segment

  2017influential citation
• Phosphodiesterase Inhibitors as a Therapeutic Approach to Neuroprotection and Repair

  2017cites this paper
• Phosphodiesterase Inhibitors Sildenafil and Vardenafil Reduce Zebrafish Rod Photoreceptor Outer Segment Shedding

  2017influential citation
• Mitochondria Maintain Distinct Ca2+ Pools in Cone Photoreceptors

  2017cites this paper
• Investigation of PDE5/PDE6 and PDE5/PDE11 selective potent tadalafil-like PDE5 inhibitors using combination of molecular modeling approaches, molecular fingerprint-based virtual screening protocols and structure-based pharmacophore development

  2017cites this paper
• Discovery of Clinical Candidate N-((1S)-1-(3-Fluoro-4-(trifluoromethoxy)phenyl)-2-methoxyethyl)-7-methoxy-2-oxo-2,3-dihydropyrido[2,3-b]pyrazine-4(1H)-carboxamide (TAK-915): A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor for the Treatment of Cognitive Disorders.

  2017cites this paper
• Inhibition of PDE5A1 guanosine cyclic monophosphate (cGMP) hydrolysing activity by sildenafil analogues that inhibit cellular cGMP efflux

  2017influential citation
• ERECTILE DYSFUNCTION AND ITS PHARMACOLOGY: AN OVERVIEW

  2017cites this paper
• Can Cyclic Nucleotide Phosphodiesterase Inhibitors Be Drugs for Parkinson’s Disease?

  2016cites this paper
• Discovery of Potent and Selective Inhibitors of Phosphodiesterase 1 for the Treatment of Cognitive Impairment Associated with Neurodegenerative and Neuropsychiatric Diseases.

  2016cites this paper
• cGMP-Phosphodiesterase Inhibition Prevents Hypoxia-Induced Cell Death Activation in Porcine Retinal Explants

  2016cites this paper
• In Search of Enzymes with a Role in 3′, 5′-Cyclic Guanosine Monophosphate Metabolism in Plants

  2016cites this paper
• Papel del estrés oxidativo y la inflamación en la retinosis pigmentaria. Efecto de la inhibición del TNFA en la progresión de la degeneración retiniana.

  2015cites this paper
• Phosphodiesterases and the Effects of Forskolin

  2015cites this paper
• Downstream effectors of cyclic adenosine monophosphate signalling in Trypanosoma brucei

  2015cites this paper
• Sildenafil-induced reversible impairment of rod and cone phototransduction in monkeys.

  2015cites this paper
• Vinpocetine modulates metabolic activity and function during retinal ischemia.

  2015cites this paper
• Sildenafil Acutely Decreases Visual Responses in ON and OFF Retinal Ganglion Cells.

  2015influential citation
• Phosphodiesterase 5 inhibitors augment UT-15C-stimulated ATP release from erythrocytes of humans with pulmonary arterial hypertension

  2015cites this paper
• Knockout of PARG110 confers resistance to cGMP-induced toxicity in mammalian photoreceptors

  2014cites this paper
• How long does a photoreceptor cell take to die? Implications for the causative cell death mechanisms.

  2014cites this paper
• Infliximab reduces Zaprinast-induced retinal degeneration in cultures of porcine retina

  2014cites this paper
• Phosphodiesterase inhibition induces retinal degeneration, oxidative stress and inflammation in cone-enriched cultures of porcine retina.

  2013cites this paper
• Early alterations in mitochondrial reserve capacity; a means to predict subsequent photoreceptor cell death

  2013cites this paper
• Avanafil, a highly selective phosphodiesterase type 5 inhibitor for erectile dysfunction, shows good safety profiles for retinal function and hemodynamics in anesthetized dogs.

  2013cites this paper
• Retinitis pigmentosa: rapid neurodegeneration is governed by slow cell death mechanisms

  2013cites this paper
• Inhibition of Mitochondrial Pyruvate Transport by Zaprinast Causes Massive Accumulation of Aspartate at the Expense of Glutamate in the Retina*

  2013influential citation
• Pharmacological Potential of PDE5 Inhibitors for the Treatment of Cystic Fibrosis

  2012cites this paper
• Mechanisms of cone photoreceptor cell death in models for inherited retinal degeneration.

  2012cites this paper
• Pharmacological Potential of PDE 5 Inhibitors for the Treatment of Cystic Fibrosis

  2012cites this paper
• Light-Driven Calcium Signals in Mouse Cone Photoreceptors

  2012cites this paper
• Chronic PDE-5 inhibition in patients with erectile dysfunction – a treatment approach using tadalafil once-daily

  2012cites this paper
• Identification of Amino Acid Residues Responsible for the Selectivity of Tadalafil Binding to Two Closely Related Phosphodiesterases, PDE5 and PDE6*

  2012influential citation
• PDE5 Inhibitors as Potential Tools in the Treatment of Cystic Fibrosis

  2012cites this paper
• CURRENT STATUS AND FUTURE PROSPECTS OF PDE5 INHIBITORS FOR VARIOUS THERAPEUTIC IMPLICATIONS

  2012cites this paper
• Inhibition of cyclic nucleotide phosphodiesterases by methylxanthines and related compounds.

  2011cites this paper
• Phosphodiesterase inhibitors: factors that influence potency, selectivity, and action.

  2011cites this paper
• Role of Neuropeptide Y in Depression: Current Status

  2011cites this paper
• Further Observations on Visual Perception: The Influence of Pathologies Upon the Absorption of Light and Emission of Bioluminescence

  2011cites this paper
• Phosphodiesterase 6C, cGMP-specific cone alpha'.

  2011cites this paper
• Phosphodiesterase 6 subunits are expressed and altered in idiopathic pulmonary fibrosis

  2010cites this paper
• Function and Regulation of Photoreceptor Phosphodiesterase (PDE6) in the Visual Signaling Pathway

  2010cites this paper
• Phosphodiesterase 5 Inhibition Improves Synaptic Function, Memory, and Amyloid-β Load in an Alzheimer's Disease Mouse Model

  2009influential citation
• Structural Requirements of the Photoreceptor Phosphodiesterase γ-Subunit for Inhibition of Rod PDE6 Holoenzyme and for Its Activation by Transducin*

  2009cites this paper
• Chronische PDE-5-Hemmung bei erektiler Dysfunktion

  2009cites this paper
• Cyclic GMP-hydrolyzing phosphodiesterases.

  2009cites this paper
• Cyclic GMP Signaling Is Involved in the Luteinizing Hormone-Dependent Meiotic Maturation of Mouse Oocytes1

  2009cites this paper
• Structural basis of phosphodiesterase 6 inhibition by the C‐terminal region of the γ‐subunit

  2009cites this paper
• Probing the Catalytic Sites and Activation Mechanism of Photoreceptor Phosphodiesterase Using Radiolabeled Phosphodiesterase Inhibitors*

  2009cites this paper
• Light stimulation evokes two different calcium responses in Müller glial cells of the guinea pig retina

  2009cites this paper
• Role of cGMP Phosphodiesterases in Idiopathic Pulmonary Fibrosis

  2009cites this paper
• Update on erectile dysfunction treatment for aging men

  2008cites this paper